Home / Pertussis, Purified Antigen, Combinations with Toxoids / Switzerland
CH ATC J07AJ52 · updated 2 Nov 2026
Pertussis, Purified Antigen, Combinations with Toxoids shortage in Switzerland
Is there a Pertussis, Purified Antigen, Combinations with Toxoids shortage in Switzerland?
Yes. As of 2 Nov 2026, 2 Pertussis, Purified Antigen, Combinations with Toxoids products are reported short in Switzerland, the first since 31 Jul 2026. The company estimate for the return is 1 Jan 2027. Main reason: not stated.
Also short in Italy, Belgium. All countries.
Affected products in Switzerland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | BOOSTRIX Inj Susp (n Fertspr) Fertspr 0.5 ml BOOSTRIX Inj Susp (n Fertspr) 10 Fertspr 0.5 ml | GlaxoSmithKline AG | 31 Jul 2026 | not given | Not stated |
| CH | ADACEL Inj Susp m Nadel Fertspr 0.5 ml ADACEL Inj Susp o Nadel 10 Fertspr 0.5 ml | Sanofi-Aventis (Suisse) SA | 31 Aug 2026 | 1 Jan 2027 | Not stated |
Source
FONES (Federal Office for National Economic Supply), reporting office for vital medicines. Official list. Vital human medicines only (the federal list of reportable active substances); one row per pack (GTIN).